Local Excision After Neoadjuvant Chemoradiotherapy in Carefully Selected Patients Initially Scheduled for Abdominoperineal Resection: Oncological Outcomes and Feasibility of Organ Preservation

For millions of people diagnosed with rectal cancer, the path to recovery has long been defined by a stark trade-off. When a tumor sits very low in the pelvis, close to the muscles that control bowel movements, the standard treatment has traditionally been a radical surgery known as an abdominoperineal resection. This procedure removes the rectum and the anal sphincter, leaving the patient with a permanent opening in the abdomen to collect waste. While this surgery is highly effective at removing the cancer, it fundamentally changes a person's life and body. In recent years, doctors have developed a way to shrink these tumors before surgery using a combination of radiation and chemotherapy. For some patients, this treatment works so well that the tumor disappears completely or leaves behind only a tiny, invisible trace. This success has sparked a difficult question: if the cancer seems to be gone, is it still necessary to perform the radical surgery that removes the sphincter, or can doctors simply remove the remaining scar tissue and leave the organ intact?

A team of researchers at Fujian Medical University Union Hospital in China set out to answer this question for a specific group of patients who were originally told they would need the radical surgery. They focused on individuals whose tumors were so low or invasive that the standard plan was to remove the entire sphincter complex. After these patients received their preoperative radiation and chemotherapy, the medical team re-evaluated them. Those who showed a complete or near-complete disappearance of the tumor were offered a different path: a local excision. Instead of removing the whole organ, surgeons would carefully cut out just the area where the tumor had been, aiming to preserve the patient's natural ability to control their bowels. The researchers followed 134 of these carefully selected patients over several years to see if this organ-preserving approach was safe and effective, or if it carried hidden dangers that the standard surgery would have avoided.

The study revealed that for many of these patients, the less invasive approach worked remarkably well. After the local excision, the pathologists examined the removed tissue under a microscope. In more than three-quarters of the cases, they found no trace of cancer cells at all. In another small group, only a tiny amount of cancer remained, and in the rest, the cancer was still present but confined to a shallow layer. Crucially, the researchers found that the patients who were originally scheduled for the radical surgery fared just as well as those who were always intended to have their sphincter saved. Over the course of the study, which followed patients for an average of about three years, the survival rates were nearly identical between the two groups. The vast majority of patients remained free of cancer, and most importantly, the overwhelming majority kept their natural sphincter and avoided a permanent stoma. The rate of cancer returning in the same spot was low, occurring in only a small fraction of the patients, and when it did return, it was often caught early enough to be treated with further surgery.

However, the path to organ preservation was not without its challenges. The researchers noted that the local excision procedure itself came with a higher rate of immediate physical discomfort than might be expected. More than four out of ten patients experienced complications after the operation, most commonly pain around the anus or slow healing of the wound where the tissue was removed. These issues were often managed with medication, drainage, or temporary measures, but they highlighted that saving the organ does not mean the recovery is always easy. The study also identified specific factors that might make this approach riskier. Patients whose tumors originally wrapped around more than half of the rectal wall seemed to have a higher chance of the cancer coming back, suggesting that the extent of the original disease matters even if the tumor shrinks significantly. Additionally, the experience level of the surgeon appeared to play a role, with more experienced surgeons achieving slightly better outcomes, though the difference was not statistically definitive.

The findings suggest that for a carefully chosen group of patients, the dream of avoiding a permanent stoma is a reality, even for those with very low or advanced tumors. The study indicates that when a tumor responds dramatically to preoperative treatment, removing just the scar tissue can offer a survival rate that matches the radical surgery, without the permanent loss of bowel control. Yet, the researchers caution that this is not a one-size-fits-all solution. The risk of the cancer returning, while low, is not zero, and the recovery can be physically demanding. The success of this strategy depends heavily on strict selection criteria, ensuring that only those with the best response to initial treatment and favorable tumor characteristics are offered this alternative. For the patients who fit these criteria, the study provides strong evidence that they can navigate a path that preserves their quality of life without sacrificing their safety, offering a hopeful alternative to the traditional, life-altering surgery that has been the standard for decades.